Disrupted myelin homeostasis in grey matter of Alzheimer's disease
Assia TianeiD, Emily WillemsiD, Lisa KooleiD, Melissa SchepersiD, Daniël van den HoveiD, Tim VanmierloiD
Abstract
Alzheimers disease (AD) is characterized not only by amyloid-{beta} plaques, tau neurofibrillary tangles and associated neuronal loss, but also by alterations in non-neuronal cell types essential for neuronal support. Oligodendrocytes and their myelin sheaths play a central role in maintaining axonal function, yet detailed molecular profiling of myelin dynamics in the human AD brain remains limited. Although neuroimaging studies increasingly highlight myelin degeneration in white matter as an important contributor to AD pathophysiology, the status of myelin within cortical grey matter is less well understood. Here, we performed a detailed histopathological characterization of myelin integrity and oligodendrocyte dynamics in both grey and white matter of the middle temporal gyrus (MTG), making use of post-mortem tissue from AD cases (n = 15) and age-, sex-, and APOE genotype-matched controls (n = 15). Strikingly, we identified a specific vulnerability of cortical grey matter myelin in AD, whereas white matter myelin appeared relatively preserved. This selective grey matter disruption was accompanied by a seemingly insufficient oligodendrocyte regenerative response, suggesting ongoing attempts at myelin repair, yet featured by a differentiation block. Importantly, the extent of myelin damage and OPC differentiation strongly correlated with proximity to tau pathology, linking cortical demyelination to neuronal and synaptic dysfunction within vulnerable AD regions. Together, our findings reveal cortical grey matter myelin disruption as a previously underrecognized, highly localized feature of AD pathology. By highlighting the tight intertwining of oligodendrocyte and myelin dynamics with tau-associated neurodegeneration, this work positions cortical myelin pathology as a potential new mechanistic and therapeutic avenue in AD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ageing-associated myelin dysfunction drives amyloid deposition in mouse models of Alzheimer's disease
Constanze Depp, Ting Sun, … Klaus‐Armin Nave·NaturePeer-reviewed·May 31, 2023
- Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease
Aurélien M. Badina, Kelly Ceyzériat, … Benjamin B. Tournier·Neurobiology of DiseasePeer-reviewed·May 8, 2025
- Myelin maturation failure and oligodendrocyte precursor loss underlie default mode network disruption in a humanized APP knock-in model of Alzheimers disease
Esmin Unaran, Olamide Elizabeth Adebiyi, … Ravi S. Menon·bioRxiv·Aug 22, 2026
- Plaque-associated oligodendrocyte proteostatic failure underlies myelin loss in Alzheimers disease
Jong Shin, Nandita Joshi, … Bilal Çakır·bioRxiv·Aug 6, 2026
- Cuprizone drives divergent neuropathological changes in different mouse models of Alzheimer's disease
Gerald Wai‐Yeung Cheng, Iris Wai-Ting Ma, … Kai‐Hei Tse·bioRxiv·Jul 24, 2023
- Amyloid-beta, p-tau, and reactive microglia load are correlates of MRI cortical atrophy in Alzheimer's disease
Irene Frigerio, Baayla D.C. Boon, … Laura E. Jonkman·bioRxiv·Jun 16, 2021